Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia

Benralizumab is indicated as add-on therapy in patients with uncontrolled, severe eosinophilic asthma; it has not yet been evaluated in a large Asian population with asthma in a clinical trial.

Source: Respiratory Medicine - April 1, 2024 Category: Respiratory Medicine Authors: Kefang Lai, Dejun Sun, Ranran Dai, Ronnie Samoro, Hae-Sim Park, Annika Åstrand, David Cohen, Maria Jison, Vivian H. Shih, Viktoria Werkström, Yuhui Yao, Yajuan Zhang, Wenying Zheng, Nanshan Zhong, the MIRACLE Study Investigators, Principle investigators Tags: Original Research Source Type: research